Part 11/14:
The scientific community is also exploring innovative approaches such as human challenge trials in the UK, where volunteers knowingly expose themselves to the virus to expedite efficacy data. Despite inherent risks, these trials could dramatically shorten timelines, potentially allowing earlier access to effective vaccines for vulnerable populations.